Colorectal Cancer - Global Market Outlook (2017-2026)

Published Date : Sep 2019 | No. of Pages : 137 Pages | Category : Healthcare

According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% during the forecast period. Introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations are some of the factors fuelling the market growth. However, factors such as the reluctance toward colorectal cancer medications on the part of patients and a lack of awareness in many parts of the world will pose a threat to the growth of the overall market.

Colorectal cancer (CRC) is one of the "big four" tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together. CRC is believed to arise as a result of interactions between inherited and environmental factors. Despite improved prognosis of CRC patients in the last decade following advances in treatment options, survival rates still lag behind those of breast and prostate cancer patients.

Based on therapies & drugs, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy propels the industry growth during the forecast period. By Geography, North America is a key region in the market and estimated to have a lucrative growth in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer.

Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen Inc., Clinical Genomics, EDP Biotech, Epigenomics AG, Hoffmann-La Roche AG, Novigenix SA, Quest Diagnostics, Sanofi SA, Siemens Healthineers and VolitionRX.

Therapies & Drugs Covered:
• Chemo Therapy
• Immuno Therapy
• Radiation Therapy
• Surgery
• Others Therapies & Drugs

Testing & Diagnosis Covered:
• Immunochemistry
• Macroscopy
• Microscopy
• Staging
• Tumor Budding

Procedures Covered:
• Biopsy
• Colostomy
• Magnetic Resonance Imaging (MRI)
• Mammography
• Sigmoidoscopy

Products Covered:
• Flow Cytometry
• In Situ Hybridization
• Microarrays
• Next-Generation Sequencing
• Targeted Therapy

Applications Covered:
• Hospitals and Clinics
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Featured Research Reports

  • Featured Research Reports

    Global Cranial Implants Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Transfusion Technology Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Wearable Medical Devices Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Cardiac Ablation Technologies Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...
  • Featured Research Reports

    Global Particle Therapy Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

    Read more...